Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Mitsubishi Ufj Morgan Stanley Securities Co., Ltd.

  • $7.89 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
SELL
$705.89 - $766.39 $42,353 - $45,983
-60 Reduced 50.0%
60 $43,000
Q1 2022

May 04, 2022
SELL
$595.12 - $698.43 $71,414 - $83,811
-120 Reduced 50.0%
120 $84,000
Q4 2021

Feb 10, 2022
BUY
$543.48 - $670.97 $5,434 - $6,709
10 Added 4.35%
240 $152,000
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $45,922 - $54,476
80 Added 53.33%
230 $139,000
Q2 2021

Aug 11, 2021
BUY
$472.8 - $558.54 $70,920 - $83,781
150 New
150 $84,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Portfolio

Follow Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email